Literature DB >> 9368995

Ancillary therapy of bovine respiratory disease.

M Apley1.   

Abstract

Ancillary therapy for bovine respiratory disease is covered with an emphasis on anti-inflammatories. Theoretic rationale and any available clinical data are reviewed for glucocorticosteroids as well as nonsteroidal anti-inflammatory drugs such as phenylbutazone, flunixin meglumine, and aspirin. Antihistamines, immunomodulators, diuretics, and bronchodilators are also discussed.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9368995     DOI： 10.1016/s0749-0720(15)30314-5

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN： 0749-0720            Impact factor:   3.357


  5 in total

1.  Impact of meloxicam on respiratory virus titers and health outcomes when administered concurrently with a modified live respiratory vaccine in abruptly weaned beef steers.

Authors:  Elizabeth R Homerosky; Michael J Jelinski; Craig Dorin
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

Review 2.  Is innate immunity our best weapon for flattening the curve?

Authors:  Leonard Angka; Marisa Market; Michele Ardolino; Rebecca C Auer
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

3.  Bovine coronavirus associated syndromes.

Authors:  Mélanie J Boileau; Sanjay Kapil
Journal:  Vet Clin North Am Food Anim Pract       Date:  2010-03       Impact factor: 3.357

Review 4.  Extremophilic SHMTs: from structure to biotechnology.

Authors:  Sebastiana Angelaccio
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

5.  Use of fever detection in combination with thoracic ultrasonography to identify respiratory disease, and compare treatments of antimicrobials and NSAID: a randomised study in dairy calves.

Authors:  Sophie A Mahendran
Journal:  Vet Rec Open       Date:  2020-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.